Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:08 AM
Study NCT ID:
NCT05332834
Status:
COMPLETED
Last Update Posted:
2024-09-27
First Post:
2022-03-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects
Sponsor:
SinoMab BioScience Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-31
First Submit QC Date:
None
Study First Post Date:
2022-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-25
Last Update Post Date:
2024-09-27
Last Update Post Date Type:
ACTUAL